Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All-Cause Mortality
Heart - United Kingdom
doi 10.1136/heartjnl-2015-309223
Full Text
Open PDFAbstract
Available in full text
Date
July 26, 2016
Authors
Publisher
BMJ